臓器移植免疫抑制薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Organ Transplantation Immunosuppressive Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16302 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、臓器移植免疫抑制薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。臓器移植免疫抑制薬の種類別市場規模（カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド）、用途別市場規模（腎臓移植、骨髄移植、肝臓移植、心臓移植、肺移植、その他移植）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Pfizer、Bristol-Myers Squibb Company、Allergan Plc、Novartis AG、Astellas Pharma、Veloxis Pharmaceuticals A/S、GlaxoSmithKline plc、Roche、Sanofi S.A. ・地域別グローバル市場分析 2015年-2020年 ・臓器移植免疫抑制薬の北米市場（アメリカ、カナダ、メキシコ） ・臓器移植免疫抑制薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・臓器移植免疫抑制薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・臓器移植免疫抑制薬の南米市場（ブラジル、アルゼンチン） ・臓器移植免疫抑制薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド ・用途別分析：腎臓移植、骨髄移植、肝臓移植、心臓移植、肺移植、その他移植 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Organ Transplantation Immunosuppressive Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Organ Transplantation Immunosuppressive Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Organ Transplantation Immunosuppressive Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Organ Transplantation Immunosuppressive Drug market has been segmented into:
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids

By Application, Organ Transplantation Immunosuppressive Drug has been segmented into:
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Organ Transplantation Immunosuppressive Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Organ Transplantation Immunosuppressive Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Organ Transplantation Immunosuppressive Drug market.

The report offers in-depth assessment of the growth and other aspects of the Organ Transplantation Immunosuppressive Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Organ Transplantation Immunosuppressive Drug Market Share Analysis
Organ Transplantation Immunosuppressive Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Organ Transplantation Immunosuppressive Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Organ Transplantation Immunosuppressive Drug sales, revenue and market share for each player covered in this report.

The major players covered in Organ Transplantation Immunosuppressive Drug are:
AbbVie
Pfizer
Bristol-Myers Squibb Company
Allergan Plc
Novartis AG
Astellas Pharma
Veloxis Pharmaceuticals A/S
GlaxoSmithKline plc
Roche
Sanofi S.A.

レポート目次

---

Table of Contents

1 Organ Transplantation Immunosuppressive Drug Market Overview
1.1 Product Overview and Scope of Organ Transplantation Immunosuppressive Drug
1.2 Classification of Organ Transplantation Immunosuppressive Drug by Type
1.2.1 Global Organ Transplantation Immunosuppressive Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type in 2019
1.2.3 Calcineurin Inhibitors
1.2.4 Antiproliferative Agents
1.2.5 mTOR Inhibitors
1.2.6 Antibodies
1.2.7 Steroids
1.3 Global Organ Transplantation Immunosuppressive Drug Market by Application
1.3.1 Overview: Global Organ Transplantation Immunosuppressive Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lungs Transplant
1.3.7 Others Transplant
1.4 Global Organ Transplantation Immunosuppressive Drug Market by Regions
1.4.1 Global Organ Transplantation Immunosuppressive Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Organ Transplantation Immunosuppressive Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Organ Transplantation Immunosuppressive Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Organ Transplantation Immunosuppressive Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Organ Transplantation Immunosuppressive Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Organ Transplantation Immunosuppressive Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Organ Transplantation Immunosuppressive Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb Company SWOT Analysis
2.3.4 Bristol-Myers Squibb Company Product and Services
2.3.5 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan Plc
2.4.1 Allergan Plc Details
2.4.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan Plc SWOT Analysis
2.4.4 Allergan Plc Product and Services
2.4.5 Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis AG SWOT Analysis
2.5.4 Novartis AG Product and Services
2.5.5 Novartis AG Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Astellas Pharma
2.6.1 Astellas Pharma Details
2.6.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Astellas Pharma SWOT Analysis
2.6.4 Astellas Pharma Product and Services
2.6.5 Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Veloxis Pharmaceuticals A/S
2.7.1 Veloxis Pharmaceuticals A/S Details
2.7.2 Veloxis Pharmaceuticals A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Veloxis Pharmaceuticals A/S SWOT Analysis
2.7.4 Veloxis Pharmaceuticals A/S Product and Services
2.7.5 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline plc SWOT Analysis
2.8.4 GlaxoSmithKline plc Product and Services
2.8.5 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi S.A.
2.10.1 Sanofi S.A. Details
2.10.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi S.A. SWOT Analysis
2.10.4 Sanofi S.A. Product and Services
2.10.5 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Organ Transplantation Immunosuppressive Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Organ Transplantation Immunosuppressive Drug Players Market Share
3.2.2 Top 10 Organ Transplantation Immunosuppressive Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Organ Transplantation Immunosuppressive Drug Revenue and Market Share by Regions
4.2 North America Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
4.5 South America Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
5 North America Organ Transplantation Immunosuppressive Drug Revenue by Countries
5.1 North America Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
5.2 USA Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
6 Europe Organ Transplantation Immunosuppressive Drug Revenue by Countries
6.1 Europe Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
6.2 Germany Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
6.3 UK Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
6.4 France Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Countries
7.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
7.2 China Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
7.5 India Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
8 South America Organ Transplantation Immunosuppressive Drug Revenue by Countries
8.1 South America Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
8.2 Brazil Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Organ Transplantation Immunosuppressive Drug by Countries
9.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Organ Transplantation Immunosuppressive Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Organ Transplantation Immunosuppressive Drug Market Forecast by Type (2019-2024)
10.3 Calcineurin Inhibitors Revenue Growth Rate (2015-2025)
10.4 Antiproliferative Agents Revenue Growth Rate (2015-2025)
10.5 mTOR Inhibitors Revenue Growth Rate (2015-2025)
10.6 Antibodies Revenue Growth Rate (2015-2025)
10.7 Steroids Revenue Growth Rate (2015-2025)
11 Global Organ Transplantation Immunosuppressive Drug Market Segment by Application
11.1 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Application (2015-2020)
11.2 Organ Transplantation Immunosuppressive Drug Market Forecast by Application (2019-2024)
11.3 Kidney Transplant Revenue Growth (2015-2020)
11.4 Bone Marrow Transplant Revenue Growth (2015-2020)
11.5 Liver Transplant Revenue Growth (2015-2020)
11.6 Heart Transplant Revenue Growth (2015-2020)
11.7 Lungs Transplant Revenue Growth (2015-2020)
11.8 Others Transplant Revenue Growth (2015-2020)
12 Global Organ Transplantation Immunosuppressive Drug Market Size Forecast (2021-2025)
12.1 Global Organ Transplantation Immunosuppressive Drug Market Size Forecast (2021-2025)
12.2 Global Organ Transplantation Immunosuppressive Drug Market Forecast by Regions (2021-2025)
12.3 North America Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
12.4 Europe Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
12.6 South America Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Organ Transplantation Immunosuppressive Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Organ Transplantation Immunosuppressive Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie Organ Transplantation Immunosuppressive Drug Major Business
Table 7. AbbVie Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 10. AbbVie Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Organ Transplantation Immunosuppressive Drug Major Business
Table 13. Pfizer Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 16. Pfizer Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Major Business
Table 19. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb Company SWOT Analysis
Table 21. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 22. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Plc Corporate Information, Location and Competitors
Table 24. Allergan Plc Organ Transplantation Immunosuppressive Drug Major Business
Table 25. Allergan Plc Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 26. Allergan Plc SWOT Analysis
Table 27. Allergan Plc Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 28. Allergan Plc Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis AG Corporate Information, Location and Competitors
Table 30. Novartis AG Organ Transplantation Immunosuppressive Drug Major Business
Table 31. Novartis AG Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 32. Novartis AG SWOT Analysis
Table 33. Novartis AG Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 34. Novartis AG Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Astellas Pharma Corporate Information, Location and Competitors
Table 36. Astellas Pharma Organ Transplantation Immunosuppressive Drug Major Business
Table 37. Astellas Pharma Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 38. Astellas Pharma SWOT Analysis
Table 39. Astellas Pharma Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 40. Astellas Pharma Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Veloxis Pharmaceuticals A/S Corporate Information, Location and Competitors
Table 42. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Major Business
Table 43. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 44. Veloxis Pharmaceuticals A/S SWOT Analysis
Table 45. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 46. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 48. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Major Business
Table 49. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 50. GlaxoSmithKline plc SWOT Analysis
Table 51. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 52. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Organ Transplantation Immunosuppressive Drug Major Business
Table 55. Roche Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 58. Roche Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sanofi S.A. Corporate Information, Location and Competitors
Table 60. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Major Business
Table 61. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Total Revenue (USD Million) (2017-2018)
Table 62. Sanofi S.A. SWOT Analysis
Table 63. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Product and Solutions
Table 64. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Players (2015-2020)
Table 66. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Players (2015-2020)
Table 67. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Regions (2015-2020)
Table 69. North America Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
Table 70. North America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Table 71. Europe Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Organ Transplantation Immunosuppressive Drug Revenue by Countries (2015-2020)
Table 74. South America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Table 77. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) by Type (2015-2020)
Table 78. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Type (2015-2020)
Table 79. Global Organ Transplantation Immunosuppressive Drug Revenue Forecast by Type (2021-2025)
Table 80. Global Organ Transplantation Immunosuppressive Drug Revenue by Application (2015-2020)
Table 81. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application (2015-2020)
Table 82. Global Organ Transplantation Immunosuppressive Drug Revenue Forecast by Application (2021-2025)
Table 83. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Organ Transplantation Immunosuppressive Drug Picture
Figure 2. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type in 2019
Figure 3. Calcineurin Inhibitors Picture
Figure 4. Antiproliferative Agents Picture
Figure 5. mTOR Inhibitors Picture
Figure 6. Antibodies Picture
Figure 7. Steroids Picture
Figure 8. Organ Transplantation Immunosuppressive Drug Revenue Market Share by Application in 2019
Figure 9. Kidney Transplant Picture
Figure 10. Bone Marrow Transplant Picture
Figure 11. Liver Transplant Picture
Figure 12. Heart Transplant Picture
Figure 13. Lungs Transplant Picture
Figure 14. Others Transplant Picture
Figure 15. Global Organ Transplantation Immunosuppressive Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Organ Transplantation Immunosuppressive Drug Revenue Market Share in 2019
Figure 24. Global Top 10 Players Organ Transplantation Immunosuppressive Drug Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Regions (2015-2020)
Figure 28. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Regions in 2018
Figure 29. North America Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 30. Europe Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 32. South America Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 34. North America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Figure 35. North America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries in 2019
Figure 36. USA Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 37. Canada Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 39. Europe Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries in 2019
Figure 41. Germany Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 42. UK Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 43. France Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 44. Russia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 45. Italy Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries in 2019
Figure 48. China Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 49. Japan Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 50. Korea Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 51. India Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 53. South America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Figure 54. South America Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries in 2019
Figure 55. Brazil Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 60. UAE Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Organ Transplantation Immunosuppressive Drug Revenue and Growth Rate (2015-2020)
Figure 63. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Type (2015-2020)
Figure 64. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Type in 2019
Figure 65. Global Organ Transplantation Immunosuppressive Drug Market Share Forecast by Type (2021-2025)
Figure 66. Global Calcineurin Inhibitors Revenue Growth Rate (2015-2020)
Figure 67. Global Antiproliferative Agents Revenue Growth Rate (2015-2020)
Figure 68. Global mTOR Inhibitors Revenue Growth Rate (2015-2020)
Figure 69. Global Antibodies Revenue Growth Rate (2015-2020)
Figure 70. Global Steroids Revenue Growth Rate (2015-2020)
Figure 71. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application (2015-2020)
Figure 72. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application in 2019
Figure 73. Global Organ Transplantation Immunosuppressive Drug Market Share Forecast by Application (2021-2025)
Figure 74. Global Kidney Transplant Revenue Growth Rate (2015-2020)
Figure 75. Global Bone Marrow Transplant Revenue Growth Rate (2015-2020)
Figure 76. Global Liver Transplant Revenue Growth Rate (2015-2020)
Figure 77. Global Heart Transplant Revenue Growth Rate (2015-2020)
Figure 78. Global Lungs Transplant Revenue Growth Rate (2015-2020)
Figure 79. Global Others Transplant Revenue Growth Rate (2015-2020)
Figure 80. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Organ Transplantation Immunosuppressive Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
Figure 84. Europe Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
Figure 86. South America Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Organ Transplantation Immunosuppressive Drug Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---